Relationship between adherence level to statins, clinical issues and health‐care costs in real‐life clinical setting
A Dragomir, R Côté, M White, L Lalonde… - Value in …, 2010 - Wiley Online Library
Objective: Statins have been shown to reduce the risk of major cardiovascular disease. We
recognize that there is a major gap between the use of statins in actual practice and
treatment guidelines for dyslipidemia. Low adherence to statins may have a significant
impact on clinical issues and health‐care costs. The objective is to evaluate the impact of
low adherence to statins on clinical issues and direct health‐care costs. Methods: A cohort of
55,134 patients newly treated with statins was reconstructed from the Régie de l'Assurance …
recognize that there is a major gap between the use of statins in actual practice and
treatment guidelines for dyslipidemia. Low adherence to statins may have a significant
impact on clinical issues and health‐care costs. The objective is to evaluate the impact of
low adherence to statins on clinical issues and direct health‐care costs. Methods: A cohort of
55,134 patients newly treated with statins was reconstructed from the Régie de l'Assurance …
[PDF][PDF] Relationship between adherence level to statins and clinical issues and health care costs in real life clinical setting Alice Dragomir, MSc and
S Perreault - academia.edu
… The aims of our study were: - To evaluate the impact of adherence to statin agents on the
incidence of cardiovascular issues in primary prevention; - To evaluate the impact of
adherence to statin agents on health care costs. …
incidence of cardiovascular issues in primary prevention; - To evaluate the impact of
adherence to statin agents on health care costs. …
以上显示的是最相近的搜索结果。 查看全部搜索结果